JPS6233114A - Tableting method of foaming bath agent - Google Patents
Tableting method of foaming bath agentInfo
- Publication number
- JPS6233114A JPS6233114A JP17292585A JP17292585A JPS6233114A JP S6233114 A JPS6233114 A JP S6233114A JP 17292585 A JP17292585 A JP 17292585A JP 17292585 A JP17292585 A JP 17292585A JP S6233114 A JPS6233114 A JP S6233114A
- Authority
- JP
- Japan
- Prior art keywords
- lubricant
- tableting
- bath agent
- foaming
- granules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、洛中で発泡しつつ溶解する浴用材料、いわゆ
る発泡性浴用錠剤(以下単に浴用錠剤という)の製造方
法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing a bath material that foams and dissolves in a bath, a so-called effervescent bath tablet (hereinafter simply referred to as a bath tablet).
従来技術とその問題点
公知の浴用錠剤は、通常クエン酸、コハク1ソ、シんご
酸、酒石酸等の有機噛と炭酸ナトリウム、炭酸水素ナト
リウム、炭酸カリウム、炭酸水素カリウム等の炭酸塩と
を主成分とし、更に所望の浴用効果等に応じて、硫酸ナ
トリウム、塩化すトリウム、ホウ酸、生薬、油脂類、香
料、色素等を適宜配合した組成を有している。そして、
錠剤化に際しては、原料配合物をそのまま直接打錠する
か、或いは原料配合物に結合剤を加えて細粒化した後打
錠することが行なわれている。結合剤としては、主成分
と反応して発泡させてしまうことがない様に、繊維素シ
リコール酸ナトリウム、ポリアクリル酸ナトリウム、メ
チル七ルO−ズ、ポリビニルじロリドン、アル千ン酸ナ
トリウム等を粉末の形態で使用して、原料配合物を乾式
造粒することが好ましいとされている。しかしながら、
従来の打錠方法においては、打錠完了後に錠剤を型(臼
ともいわれる)から取り出す際に錠剤の一部が剥離する
+ヤッヒンジ現象や、打錠時の圧縮過程で原料配合物の
一部が押型(杵ともいわれる)に付着して錠剤表面を損
傷するスデイッ牛ンク現象等の障害が発生しやすいので
、連続的な打錠は困難である。この様な問題を解決する
為に、ステアリン酸、ステアリン酸カルシウム、ステア
リ:J酸マグネシウム、ポリエチレンクリコール、安息
香酸、安息香酸ナトリウム、殿粉、タルク、シリコυ樹
脂等を滑沢剤として原料配合物に添加して打錠すること
が行なわれている。この様な滑沢剤の使用により、打錠
時の問題点は、若干軽減されたものの、浴用錠剤として
の性能が阻害されることが判明した。即ち、滑沢剤の種
類によっては、(イ)条斑の使用を必要とするので、浴
用錠剤の浴中での崩壊性を低下させる、■水に溶解しな
いので、浴に白濁を生じさせる、09浴表面に油状に浮
んで、不快感を与える、(2)浴用錠剤から発生した泡
の消滅を妨げる、等の新たな問題点を生じている。Prior Art and Problems Known bath tablets usually contain organic acids such as citric acid, succinic acid, sinlic acid, and tartaric acid, and carbonates such as sodium carbonate, sodium hydrogen carbonate, potassium carbonate, and potassium hydrogen carbonate. It has a composition in which sodium sulfate, thorium chloride, boric acid, herbal medicines, oils and fats, fragrances, pigments, etc. are appropriately blended according to the desired bath effect. and,
In tabletting, the raw material mixture is directly compressed into tablets as it is, or a binder is added to the raw material mixture to make the tablets into fine particles, which are then compressed into tablets. As a binder, sodium cellulose silicate, sodium polyacrylate, methyl heptyl-O's, polyvinyl dirolidone, sodium alsenate, etc. are used to prevent foaming due to reaction with the main component. It is said to be preferable to use it in powder form and dry granulate the raw material formulation. however,
In conventional tabletting methods, when the tablet is removed from the mold (also called a mortar) after the tableting is completed, a part of the tablet peels off + Yaching phenomenon, and a part of the raw material mixture is removed during the compression process during tabletting. Continuous tableting is difficult because problems such as the slug-ink phenomenon, in which tablets adhere to the press die (also called a punch) and damage the tablet surface, are likely to occur. In order to solve these problems, we have developed a raw material blend containing stearic acid, calcium stearate, magnesium stearate, polyethylene glycol, benzoic acid, sodium benzoate, starch, talc, silico resin, etc. as lubricants. It is done by adding it to tablets. Although the use of such a lubricant somewhat alleviated the problems encountered during tableting, it was found that the performance as bath tablets was impaired. That is, depending on the type of lubricant, (a) it requires the use of stripes, which reduces the disintegration properties of bath tablets in the bath, and (i) it does not dissolve in water, causing cloudiness in the bath. No. 09 new problems have arisen, such as floating in an oily state on the surface of the bath, giving a feeling of discomfort, and (2) preventing the disappearance of bubbles generated from the bath tablets.
本発明者は、この様な現状に鑑みて種々研究を重ねた結
果、アジピン酸とそのアルカリ金属塩が、浴用錠剤の打
錠製造時の滑沢剤として優れた効果を発揮するのみなら
ず、浴用錠剤としての性能を損なわないことを見出した
。即ち、本発明は、発泡性浴用剤を打錠するに際し、滑
沢剤としてアジピン酸及びアジピン酸のアルカリ金属塩
の少なくとも1種を添加することを特徴とする発泡性浴
用剤の打ム1方法に係る。The present inventor has conducted various studies in view of the current situation, and has found that adipic acid and its alkali metal salts not only exhibit excellent effects as lubricants during the production of bath tablets, but also It was found that the performance as a bath tablet was not impaired. That is, the present invention provides a method for compressing foaming bath preparations, which comprises adding at least one of adipic acid and an alkali metal salt of adipic acid as a lubricant when tabletting the foaming bath preparations. Pertains to.
本発明で使用する滑沢剤以外の浴用錠剤成分は、し、更
に必要に応じて他の添加剤を配合したものである。The bath tablet components other than the lubricant used in the present invention include: and other additives as necessary.
滑沢剤としては、アジヒ:/晒及びそのアルカリ金属塩
の少なくとも1種を使用する。アルカリ金属塩としては
、アジじン酸ナトリウム、アジピン酸水素ナトリウム、
アジピン酸カリウム、アジごン酸水素カリウム等が例示
される。As the lubricant, at least one type of Ajihi:/Sarasu and its alkali metal salt is used. Alkali metal salts include sodium adipate, sodium hydrogen adipate,
Examples include potassium adipate and potassium hydrogen adipate.
本発明方法は、例えば、次の様にして実施さnる。先ず
、クエン酸等の有Ir1AI!lllと炭酸ナトリウム
等の無機課汐を発泡性主成分とし、必要に応じこれに他
の添加J♀]を配合した原料配合物を乾式造粒機によシ
頽粒化する。該顆粒の粒径は、32〜+00メツシュ程
度であることが好ましく、必要ならば、選別して粒度詞
整を行なう。次いで、該顆粒重量の1〜lO重鼠%程度
よυ好ましくは3〜6重量%程度の割合で、アジピン酸
及びアジピン酸のアルカリ金属塩の少なくとも1種を加
え、均一に混合した後、常法に従って打錠を行なって、
浴用錠剤を得る。The method of the present invention is carried out, for example, as follows. First, Ir1AI such as citric acid! A raw material mixture containing 1ll and an inorganic substance such as sodium carbonate as the main foaming ingredients, and other additives as required, is granulated using a dry granulator. The particle size of the granules is preferably about 32 to +00 mesh, and if necessary, the granules are selected and adjusted for particle size. Next, at least one of adipic acid and an alkali metal salt of adipic acid is added in a proportion of about 1 to 10% by weight, preferably about 3 to 6% by weight of the weight of the granules, mixed uniformly, and then constantly mixed. Compress the tablets in accordance with the law,
Obtain bath tablets.
本発明によれば、浴用錠剤の打錠製造時の牛ヤッピンク
やステイッ士ジグが防止されるのみならず、使用した滑
沢剤によシ浴用錠剤の性能が阻害されることもない。According to the present invention, not only is it possible to prevent yapping and sticking jig during the production of tablets for bathing, but also the performance of the tablets for bathing is not inhibited by the lubricant used.
以下に実施例及び比較例を示し、本発明の特徴とすると
ころを更に一層明らかにする。Examples and comparative examples are shown below to further clarify the characteristics of the present invention.
実施例1〜2及び比較例1
第1表に示す囚成分から得た顆粒(32〜+00メツシ
ユ)に03)成分を添加混合し、直径35酷、厚さl0
ffの碁石状円形錠剤を打錠した。尚、第1表に示す数
値は、重taifl(を示す。Examples 1 to 2 and Comparative Example 1 Component 03) was added and mixed to the granules (32 to +00 mesh) obtained from the prison components shown in Table 1, and the mixture was made to have a diameter of 35 mm and a thickness of 10 mm.
ff stone-shaped circular tablets were compressed. In addition, the numerical values shown in Table 1 indicate the heavy duty.
滑沢剤としてタルクを使用する比較例1においては、4
錠打錠後にステイッ牛ンジ現象を生じて、打錠を継続し
得なくなったのに対し、実施例1〜2では、1000錠
以上の正常な連続打錠が可能であり、不良率も著るしく
低下した。In Comparative Example 1 using talc as a lubricant, 4
In contrast, in Examples 1 and 2, normal continuous tableting of 1000 tablets or more was possible, and the defective rate was also significant. It decreased significantly.
第 1 表
実施例3〜4及び比較例2
第2表に示す囚成分から得た顆粒(32〜100メツシ
ユ)に出)成分を添加混合し、直径4Qfj。Table 1 Examples 3 to 4 and Comparative Example 2 To the granules (32 to 100 mesh) obtained from the powder components shown in Table 2, the ingredients were added and mixed, and the diameter was 4Qfj.
厚さ2011の凸円形錠剤に打錠した。It was compressed into convex circular tablets with a thickness of 2011 mm.
滑沢剤としてポリエチレンクリコールを使用する比較例
2においては、+ヤッピンク現象が短時間内に発生し、
又錠剤の強度が十分でない為摩損が大きかった。これに
対し、実施例3〜4では、!00(l打錠後にも牛セッ
じンタ現象は発生せず、成型性に優れた錠剤が得られた
。In Comparative Example 2 in which polyethylene glycol was used as a lubricant, the +yapping phenomenon occurred within a short time,
In addition, the strength of the tablets was not sufficient, resulting in large wear and tear. On the other hand, in Examples 3 and 4,! Even after compression, the cow settling phenomenon did not occur and tablets with excellent moldability were obtained.
第 2 表
参考例
実施例1のアジと:J酸に代えて第3表に示す各物質を
滑沢剤として使用した場合の(a)打錠前の配合物の流
動性付与効果、(b)ステイッ+ンク防止効果、(ζ)
牛ヤッピンク防止効果及び(d′)浴用錠剤を温水に溶
解した際の問題点を第3表に示す。Table 2 Reference Examples When each substance shown in Table 3 is used as a lubricant in place of the azide and J acid of Example 1, (a) Effect of imparting fluidity to the formulation before tableting, (b) Sticky prevention effect, (ζ)
Table 3 shows the effect of preventing cow yapping and (d') problems when the bath tablets are dissolved in hot water.
第 3 表
−二効果なし、+:若干効果あシ、++:かなシ効果あ
り、+++:著るしく効果あシ。Table 3 - No effect, +: Slight effect, ++: Kana effect, +++: Significant effect.
(以 上) 代理人 弁理士 三 枝 英 二 。(that's all) Agent: Patent attorney Miyoshi Eiji.
手続ネ「11正書く自発〉
昭和60年9月11EJ
1 事件の表示
昭和60年持具′[願第172925号2 発明の名称
発泡性浴用剤の打錠方法
3 補正をする考
事件との関係 ¥i許出出願
人田製薬株式会社
4 代 理 人
大阪市東区平野町2の10 沢の鶴ビル(6521)
弁理士 三 枝 英 二 、 ゛・・
。Proceedings ``11 Voluntary writing'' September 1985 11 EJ 1 Indication of the case 1985 Holder' [Application No. 172925 2 Name of the invention Method for tabletting effervescent bath additives 3 Relationship with the case to be amended ¥i Permission applicant Hitota Pharmaceutical Co., Ltd. 4 Representative Sawanotsuru Building (6521) 2-10 Hirano-cho, Higashi-ku, Osaka
Patent attorney Eiji Saegusa,...
.
□′ □′
5 補正命令の日付 °8.れ/自
発
6 補正の対象
明w11m中[発明の詳細な説明]の項補正の内容
1 明細書第3頁第14行「本発明者は」とあるのを下
記の通りに1正する。□′ □′ 5 Date of amendment order °8. Re/Initiation 6 Subject of amendment Contents of amendment under [Detailed description of the invention] in w11m 1. The statement ``The inventor is'' on page 3, line 14 of the specification shall be corrected by 1 as follows.
「 問題点を 決するための手段 本発明者は 」(以 上)``Means to resolve issues The inventor is
Claims (1)
ジピン酸及びアジピン酸のアルカリ金属塩の少なくとも
1種を添加することを特徴とする発泡性浴用剤の打錠方
法。(1) A method for tabletting an effervescent bath agent, which comprises adding at least one of adipic acid and an alkali metal salt of adipic acid as a lubricant when tabletting the effervescent bath agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17292585A JPS6233114A (en) | 1985-08-05 | 1985-08-05 | Tableting method of foaming bath agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17292585A JPS6233114A (en) | 1985-08-05 | 1985-08-05 | Tableting method of foaming bath agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6233114A true JPS6233114A (en) | 1987-02-13 |
JPS6327324B2 JPS6327324B2 (en) | 1988-06-02 |
Family
ID=15950894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP17292585A Granted JPS6233114A (en) | 1985-08-05 | 1985-08-05 | Tableting method of foaming bath agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6233114A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006248937A (en) * | 2005-03-09 | 2006-09-21 | Pola Chem Ind Inc | Solid bath agent and its manufacturing method |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0512040Y2 (en) * | 1986-08-14 | 1993-03-26 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5444013A (en) * | 1977-08-15 | 1979-04-07 | Kuroisutaa Kemikaruzu Kk | Production of foamable tablet |
JPS5444722A (en) * | 1977-08-23 | 1979-04-09 | Furukawa Battery Co Ltd | Device for automatically stacking plate group for storage battery |
-
1985
- 1985-08-05 JP JP17292585A patent/JPS6233114A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5444013A (en) * | 1977-08-15 | 1979-04-07 | Kuroisutaa Kemikaruzu Kk | Production of foamable tablet |
JPS5444722A (en) * | 1977-08-23 | 1979-04-09 | Furukawa Battery Co Ltd | Device for automatically stacking plate group for storage battery |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006248937A (en) * | 2005-03-09 | 2006-09-21 | Pola Chem Ind Inc | Solid bath agent and its manufacturing method |
Also Published As
Publication number | Publication date |
---|---|
JPS6327324B2 (en) | 1988-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3773920A (en) | Sustained release medicinal composition | |
US3074852A (en) | Pharmaceuticals with delayed release | |
EP0223590B1 (en) | Substained release compositions comprising hydroxypropyl cellulose ethers | |
CA1240925A (en) | Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants | |
EP1276466B1 (en) | Directly compressed solid dosage particles | |
DE60100703T2 (en) | The Applicant's argumentation according to which none of D1-D3 teaches to perform the second stage with an upper limit in the amount of fully esterified polyols of 85% by weight is acknowledged. Therefore, an inventive step for the claimed matter 1-11 is acknowledged. PARTICLE MIXTURES AND COMPACT PRODUCTS MOLDED THEREOF, AND PRODUCTION THEREOF | |
US4734285A (en) | Sustained release compositions | |
KR840005661A (en) | Process for preparing a persistent matrix tablet composition | |
EP1843754B1 (en) | New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance | |
US3632778A (en) | Tablets containing l-dopa | |
HUP0003095A2 (en) | Cleaning compositions in the form of tablets made by compacting a quatity of the composition in particulate form and process for producing thereof | |
US3362880A (en) | Compressed drug tablets of ethyl cellulose, glyceryl monostearate, karaya gum, tragacanth, talc, and magnesium stearate | |
US3344030A (en) | Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables | |
US3976601A (en) | Water soluble lubricant for tabletting compositions | |
JPS6233114A (en) | Tableting method of foaming bath agent | |
DE4414544A1 (en) | Depot tablet | |
US3506756A (en) | Use of adipic acid as a tableting lubricant | |
US3956444A (en) | Process for producing a rapidly-soluble sodium dichloroisocyanurate dihydrate tablet | |
US4024257A (en) | Rapidly-soluble sodium dichloroisocyanurate dihydrate tablet | |
US3584099A (en) | Adipic acid as a tableting lubricant | |
Symecko et al. | Binder functionality in tabletted systems | |
US3577491A (en) | Tableting | |
DE2440383A1 (en) | PROCESS FOR THE MANUFACTURING OF EXCIPIENT-FREE TABLETS | |
US3784708A (en) | Directly compressible monocalcium phosphate | |
JPS5879917A (en) | Molding of glycine tablet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |